Oncology/Hematology Market Research Reports & Industry Analysis
Oncology/Hematology Industry Research & Market Reports
-
Legal Marijuana Market: By Type (Recreational, Medical), By Product Type (Flower, Oil and Tinctures), By Application (Chronic Pain, Mental Disorders, Cancer, Others), And Region – Global Analysis of Market Size, Share & Trends For 2021–2022 And Forecasts To 2031
... And Forecasts To 2031 The updated study by FATPOS Global Research, titled "Legal Marijuana Market Size, Share, Price, Trends, Growth, Report, and Forecast 2022-2032," provides a detailed analysis of the Legal Marijuana Market and evaluates ... Read More
-
Leukemia Therapeutics Market By Type (Acute Lymphocytic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Others), By Drug Class (Chemotherapy, Targeted Therapy and Immunotherapy), By Distribution channel (Hospital Pharmacies, Drug Store and Retail Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031
... Pharmacies, Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2031 The global leukemia therapeutics market valued for $7,818.63 million in 2021 and is estimated to reach $14,162.48 million by 2031, exhibiting a CAGR of 6.1% ... Read More
-
Mycosis Fungoides Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update
... Trial Status, Trial Counts, End Points, Status, Sponsor Type and Top Countries, 2023 Update provides an overview of Mycosis Fungoides Clinical trials scenario. This report provides top line data relating to the clinical trials on ... Read More
-
B-Cell Non-Hodgkin Lymphoma (NHL) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
... more than 1.7 million diagnosed prevalent cases of B-cell NHL across 16 pharmaceutical markets. There are a good number of marketed innovator drugs for the treatment of B-cell NHL, mostly protein/peptide inhibitors and receptor antagonists.. ... Read More
-
Global PEGylated Proteins Market Size study & Forecast, by Protein Type (Colony-stimulating factor, Interferons, Erythropoietin, Recombinant factor VII, Others), by Product & Services (Consumables, Services), by Application (Cancer, Autoimmune diseases, Hepatitis, Multiple sclerosis, Hemophilia, Gastrointestinal disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029
... disorders, Others), by End-User (Pharmaceutical & biotechnology companies, Contract research organizations, Academic & research institutes), and Regional Analysis, 2022-2029 Global PEGylated Proteins Market is valued at approximately USD 1.14 billion in 2021 and is anticipated ... Read More
-
Global Cancer Gene Therapy Market Size study & Forecast, by Type (Oncolytic Virotherapy, Gene Induced Immunotherapy, Gene Transfer), by End Use (Research Institutes, Biopharmaceutical Companies, Diagnostic Centers, Others) and Regional Analysis, 2022-2029
... Therapy Market is valued at approximately USD 1.68 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 19.99% over the forecast period 2022-2029. Cancer gene therapy is a ... Read More
-
Colorectal Cancer Screening Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033
... Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures and Forecast, 2015-2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of ... Read More
-
Ovarian Cancer Drugs Global Market Opportunities and Strategies To 2031
... information they need to assess the global ovarian cancer drugs market as it emerges from the COVID-19 shut down. Reasons to Purchase Gain a truly global perspective with the most comprehensive report available on this ... Read More
-
Global Personalized Medicine Biomarkers Market Size study & Forecast, by Indication (Oncology, Diabetes, Autoimmune Diseases, Cardiology, Others) by Application (Early Detection/Screening, Diagnosis, Treatment Selection, Monitoring) and Regional Analysis, 2022-2029
... valued at approximately USD 11.76 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 15.51% over the forecast period 2022-2029. Personalized medicine biomarkers are essential tools that are ... Read More
-
Global T-Cell Lymphoma Market Size study & Forecast, by Lymphoma Type (Peripheral T-cell Lymphoma, T-cell Lymphoblastic Lymphoma), Therapy Type (Radiotherapy, Chemotherapy, Immunotherapy, Stem Cell Transplantation, Other Types of Therapies) and Regional Analysis, 2022-2029
... Lymphoma Market is valued at approximately USD 1588.89 million in 2021 and is anticipated to grow with a healthy growth rate of more than 8.25% over the forecast period 2022-2029. T-Cell Lymphoma is a type ... Read More
-
Acute Lymphocytic Leukemia (ALL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late- clinical stage pipeline products, ... Read More
-
Chronic Lymphocytic Leukemia (CLL) Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... and 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late- clinical stage pipeline products, ... Read More
-
2023 Asia-Pacific Molecular Diagnostics Market in 18 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or marketing ... Read More
-
2023 Global Molecular Diagnostics Market in the US, Europe, Japan - 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... Tests This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies ... Read More
-
2023 Europe Molecular Diagnostics Market in France, Germany, Italy, Spain, UK - 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... Paternity Tests This database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of ... Read More
-
2023 Latin America Molecular Diagnostics Market in 22 Countries: 2022 Supplier Shares, Instrumentation Installed Base and Strategies by Country, 2022-2027 Volume and Sales Segment Forecasts for Individual Infectious, Genetic, Cancer, Forensic and Paternity Tests
... database from LeadingMarketResearch.com provides the 2022 supplier shares, the 2022-2027 volume and sales forecasts for infectious diseases, genetic diseases, cancer diagnostics, forensic and paternity testing applications, as well as comprehensive lists of companies developing or ... Read More
-
Global Soft Tissue Sarcoma Drugs Market Growth (Status and Outlook) 2023-2029
... Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Soft Tissue Sarcoma Drugs sales for 2023 through 2029. With Soft Tissue Sarcoma Drugs sales broken down by region, market ... Read More
-
Patient Positioning Systems Market by Product (Tables (Surgical Table, Imaging Table, Examination Table), Accessories, Application (Surgery, Diagnosis, Cancer Treatment), End User (Hospitals, ASCs, Diagnostic Labs)) - Global Forecast to 2027
... market is projected to reach USD 1.7 billion by 2027 from USD 1.4 billion in 2022, growing at a CAGR of 4.0% during the forecast period. The availability of government support, in funds and grants, ... Read More
-
Rare Disease Treatment Market Size By Drug (Biologics, Non-biologics), By Therapeutic Area (Cancer, Blood-related Disorders, Central Nervous System (CNS), Respiratory Disorders, Musculoskeletal Disorders, Cardiovascular Disorders), By Patient (Adult, Pediatric), By Route of Administration (Oral, Injectable), Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032
... Industry Analysis Report, Regional Outlook, Growth Potential, Application Potential, Competitive Market Share & Forecast, 2023-2032 Rare Disease Treatment Market is anticipated to grow considerably through 2032 owing to the increasing prevalence of rare diseases across ... Read More
-
Multiple Myeloma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the eight major markets (8MM) for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch ... Read More
-
Oncology Drugs Global Market Briefing 2023
... market was $28.5 and in terms of global GDP, the market was 0.20%. Oncology drugs was the second largest segment within the market accounting for 13.9% preceded and followed by anti-infective drugs at 15.5% and ... Read More
-
HER2 Amplification Tests Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast, 2015-2033
... Forecast Model (COVID-19 Market Impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on HER2 Amplification Tests market for the year ... Read More
-
Hematology Drugs Global Market Briefing 2023
... market was $4.6 and in terms of global GDP, the market was 0.03%. Hematology drugs was the twelfth largest segment within the market accounting for 2.2% preceded by genito-urinary drugs at 2.6% and dermatology drugs ... Read More
-
Cancer Vaccines Market - Growth, Trends, Covid-19 Impact, and Forecasts (2023 - 2028)
... CAGR of 11.54% during the forecast period. The COVID-19 pandemic had an adverse effect on the global economy and healthcare system. Pharmaceuticals, medical gadgets, and biotechnological items were all affected by the worldwide lockdown. Research ... Read More
-
HPV Testing & PAP Test Market Analysis and Forecast to 2032: By Test Type (HPV Test, PAP Test, Co-test), Application (Cervical Cancer, Vaginal Cancer), Location of Testing (Hospitals & Clinics, Diagnostic Centers, Others), and Region
... The global HPV testing & PAP test market was valued at USD 3.7 billion in 2022 and it is anticipated to grow further till USD 7.2 billion by 2032, at a CAGR of 6.8% during ... Read More
Research Assistance
